Concepedia

Author

Sarah N. Flier

Harvard University

Also Known As

S N Flier, S. N. Flier, S.N. Flier, Sarah Flier, Sarah N Flier, Sarah N. Flier

55

Publications

1.8K

Citations

12

H-Index

34

Concepts

All Affiliations

Harvard UniversityBeth Israel Deaconess Medical CenterJoslin Diabetes Center
SN

About

Sarah N. Flier is an author at Harvard University specializing in medicine, immunology, and gastroenterology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

3

3

1.1K

2

Gastroenterology

2

2

286

3

Public Health

1

1

772

4

Cell Biology

1

1

273

5

Endocrinology

1

1

772

Sarah N. Flier

×

11

Publications

1.7K

Citations

11

H-Index

YearCitations

Leptin accelerates the onset of puberty in normal female mice.

Rexford S. Ahima, Jody Dushay, Sarah N. Flier,

Journal of Clinical Investigation

1997

772

Altered function of insulin receptor substrate-1–deficient mouse islets and cultured β-cell lines

Rohit Kulkarni, Jonathon N. Winnay, Molly S. Daniels,

Journal of Clinical Investigation

1999

273

Identification of Epithelial to Mesenchymal Transition as a Novel Source of Fibroblasts in Intestinal Fibrosis

Sarah N. Flier, Harikrishna Tanjore, Efi Kokkotou,

Journal of Biological Chemistry

2010

273

Evidence for a circulating islet cell growth factor in insulin-resistant states

Sarah N. Flier, Rohit Kulkarni, C. Ronald Kahn

Proceedings of the National Academy of Sciences

2001

155

Intestinal, but not hepatic, ChREBP is required for fructose tolerance

Mi-Sung Kim, Inna Astapova, Sarah N. Flier,

JCI Insight

2017

89

Emergency department utilisation for inflammatory bowel disease in the United States from 2006 to 2014

Sarah Ballou, William Hirsch, Prashant Singh,

Alimentary Pharmacology & Therapeutics

2018

46

Elevated Serum Fibroblast Growth Factor 21 in Humans with Acute Pancreatitis

Vivek K. Shenoy, K.M. Beaver, Ffolliott M. Fisher,

PLoS ONE

2016

37

Patients With Low Drug Levels or Antibodies to a Prior Anti–Tumor Necrosis Factor Are More Likely to Develop Antibodies to a Subsequent Anti–Tumor Necrosis Factor

Niels Vande Casteele, María T. Abreu, Sarah N. Flier,

Clinical Gastroenterology and Hepatology

2021

27

A case confirming the progressive stages of pyomyositis

Sarah N. Flier, Stephen E. Dolgin, Richard L. Saphir,

Journal of Pediatric Surgery

2003

22

Are Expectations Too High for Transitioning Adolescents With Inflammatory Bowel Disease? Examining Adult Medication Knowledge and Self‐Management Skills

Laurie N. Fishman, Paul D. Mitchell, Paul R. Lakin,

Journal of Pediatric Gastroenterology and Nutrition

2016

17

Page 1